Another 3 Common Pesticides Are Now Linked To Parkinson’s Disease Risk

Health & Lifestyle
231

Listen to article (english)

Translate to Spanish or other 102 languages!

Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes
Three more pesticides commonly used in the United States have now been linked to heightened Parkinson’s risk. Image for illustration purposes

Medical News Today

- Advertisement -
  • Parkinson’s disease prevalence is growing fast, and similar to some other neurological conditions, its causes are unclear. 
  • The potential impact of chemicals that are toxic to neurons in the part of the brain affected by Parkinson’s disease has been investigated since the 1980s. 
  • Despite this, many chemicals, particularly pesticides and herbicides that are known to pose a risk, are still used in many parts of the world. 
  • Researchers have now identified a risk of Parkinson’s disease associated with exposure to 14 pesticides. 

Parkinson’s disease is the fastest growingTrusted Source neurological disorder in the world at present, and the reason why is unclear.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/another-3-common-pesticides-are-now-linked-to-parkinsons-disease-risk?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Salm Partners, LLC, Recalls Johnsonville Polish Kielbasa Turkey Sausage Products
Next article
Top Tips for Healthy Aging

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -